On Friday shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) closed at $6.39. Zacks downgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP) from a hold rating to a sell rating in a report issued on Wednesday.
Range Resources Corporation (NYSE:RRC) in last trading activity moved up 5.74% to close at $64.29. Company weekly performance is -0.71% while its quarterly performance stands at 24.55%. Range Resources Corporation (NYSE:RRC) is -31.62% away from its 52 week high. On May 7, Range Resources Corporation (NYSE:RRC) announced that it has priced at par an offering of $750 million aggregate principal amount of senior notes due 2025, which will carry an interest rate of 4.875%. Range expects that the net proceeds of the offering will be approximately $738 million and intends to use the net proceeds to repay borrowings under its bank credit facility pending its intended redemption of all of its 6 3/4% senior subordinated notes due 2020, which it expects to complete in August 2015 using borrowings under its bank credit facility.
On last trading day New York REIT, Inc. (NYSE:NYRT) moved up 1.41% to close at $10.07. Its volatility for the week is 1.45% while volatility for the month is 1.55%. New York REIT, Inc. (NYSE:NYRT) monthly performance is -1.18%. On May 5, New York REIT, Inc. (NYSE:NYRT), announced it will release its financial results for the fourth quarter and full year 2014 and the first quarter 2015 on Monday, May 11, 2015, after the close of the market.
Denbury Resources Inc. (NYSE:DNR) has 0.70% insider ownership. In last trading activity company’s stock closed at $7.71. On May 06, Denbury Resources (NYSE: DNR) posted a $108 million loss in the first quarter despite oil hedges that kept the company afloat. That’s down 286 percent from the first quarter of 2014 when crude oil spot prices were well over $100 a barrel. Oil prices were less than half that through much of the first quarter.
On last trading day Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) moved up 1.78% to close at $63.00. Its volatility for the week is 6.42% while volatility for the month is 5.87%. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) monthly performance is 4.88%. On May 5, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced that it will host a conference call on Monday, May 11, 2015 at 5pm ET to discuss first quarter 2015 financial results and provide a corporate update.